Literature DB >> 28960644

Succinate dehydrogenase B-deficient renal cell carcinoma: A case report with novel germline mutation.

Hiromichi Iwashita1, Koji Okudela2, Mai Matsumura2, Shoji Yamanaka1, Tomoe Sawazumi1, Makiko Enaka1, Naoko Udaka1, Akio Miyake1, Takashi Hibiya1, Noriko Miyake3, Naomichi Matsumoto3, Kazuhide Makiyama4, Masahiro Yao4, Yoji Nagashima5, Kenichi Ohashi2.   

Abstract

Succinate dehydrogenase-deficient renal cell carcinoma (SDH-deficient RCC) is a newly introduced histological type of RCC, which is caused by loss of subunit genes of SDH. It is known to frequently demonstrate familial occurrence and be frequently associated with gastrointestinal stromal tumors and paraganglioma. To date, only 53 cases have been reported. Here, we present an additional case of SDH-deficient RCC occurring in a 40-year-old female. The tumor was histologically biphasic, consisting of tubular and solid architectures. The tumor cells possessed oval nuclei with small nucleoli, and an eosinophilic granular cytoplasm with occasional vacuoles. These cells completely lost the immunohistochemical expression of B subunit of SDH (SDHB). Consequently, the tumor was diagnosed as SDHB-deficient RCC. We identified a novel germ line mutation of the SDHB gene, and also confirmed a hemizygous deletion of the wild-type allele in the tumor cells. To define the pathological characteristics of SDH-deficient RCC, precise diagnosis and accumulation of more cases are required.
© 2017 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  SDH A and B subunits (SDHA and SDHB); germline mutations; kidney; renal cell carcinoma (RCC); succinate dehydrogenase (SDH)

Mesh:

Substances:

Year:  2017        PMID: 28960644     DOI: 10.1111/pin.12587

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  4 in total

Review 1.  MicroRNA-96: A therapeutic and diagnostic tumor marker.

Authors:  Hamid Reza Rahimi; Majid Mojarrad; Meysam Moghbeli
Journal:  Iran J Basic Med Sci       Date:  2022-01       Impact factor: 2.532

Review 2.  MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer.

Authors:  Amir Abbas Hamidi; Negin Taghehchian; Zahra Basirat; Amir Sadra Zangouei; Meysam Moghbeli
Journal:  Biomark Res       Date:  2022-06-04

3.  MicroRNA-96-3p promotes metastasis of papillary thyroid cancer through targeting SDHB.

Authors:  Xupeng Zhao; Yingjie Li; Yong Zhou
Journal:  Cancer Cell Int       Date:  2019-11-12       Impact factor: 5.722

4.  Succinate dehydrogenase B-deficient renal cell carcinoma with a germline variant in a Japanese patient: a case report.

Authors:  Shinichiro Higashi; Takeshi Sasaki; Katsunori Uchida; Takumi Kageyama; Makoto Ikejiri; Ryuki Matsumoto; Manabu Kato; Satoru Masui; Yuko Yoshio; Kouhei Nishikawa; Yoshinaga Okugawa; Masatoshi Watanabe; Takahiro Inoue
Journal:  Hum Genome Var       Date:  2022-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.